Likewise, MR-proANP has been shown e.g. to improve prediction of mortality in patients with ST-segment elevation myocardial infarction [32] and to represent one of the strongest predictors of cardiovascular outcome in stable angina [33]. The gene discussed is NPPA; the disease is angina pectoris.